Wockhardt: an NiCE story

[Shreya28]

Wockhardt - A story with twist and turn

FEP-ENM or Cefepime/Enmetazobactam to be sold under brand name Exblifep has good efficacy in certain class-A beta-lactamases but overall its performance is comparable to Piperacillin/tazobactam (sold as Zosyn and gone off-patent in '23) which again is comparable to meropenems. These are not effective in MBL-producing strains is what the studies say. WCK 5222 or FEP-ZID has efficacy against all classes of ESBL and carbapenamase producers (see FEP-ENM column and compare against FEP-ZID 1:1 colum…

A question similar to this was raised by me a few days back. Hope this can help you understand this.